arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BIOMARIN PHARMACEUTICAL INC

BMRN
$63.75 ▲ +2.31 (+3.76%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
71 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Neutral
auto_awesome

Analytical Summary

BIOMARIN PHARMACEUTICAL INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $12.3B
Dividend Yield
Revenue Growth 2.8%
Op. Margin 16.9%
ROIC 1.3%
FCF / Share $1.04
Trailing P/E 115.9x
Price / Book 2.0x
FCF Yield 1.6%
Debt / Equity 0.23
info Valuation on last close. End-of-day price, Aug 7, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$766.21M
↑ +2.8%
Net Income Profit after all expenses
$105.53M
↓ -43.2%
Operating Margin Operating profit as % of sales
16.9%
↑ +431.7% 63th
FCF / Share Free cash flow per share
$1.04
↑ +25.7%

Health Breakdown

Profitability
71
Returns
55
Financial Health
94
Cash Quality
87

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters